Skip to main content
. 2019 Mar 1;12(3):700–710.

Figure 2.

Figure 2

ZSCAN10 is associated with glioma in the clinic. A. IHC analysis displayed stronger expression of ZSCAN10 in tumor tissues compared to the adjacent normal tissues. B. K-M analysis with TCGA data demonstrated that patients with high ZSCAN10 showed poor survival rate (P < 0.01).